Assessing Patient Preferences for Treatment Options and Process of Care in Inflammatory Bowel Disease: A Critical Review of Quantitative Data

Bewtra, Meenakshi

doi:10.1007/s40271-013-0031-2

Cited by 39 publications

(28 citation statements)

References 141 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Our results are consistent with a qualitative study which found that treatment benefits, particularly symptom control, rather than endoscopic remission, are the most important treatment goals [22]. Our findings are also in line with other published DCEs, which have also found that on average, treatment benefits outweigh other considerations for most patients with Crohn's disease [7,[23][24][25]. Other studies have also found similar latent classes, with groups of patients that are averse to corticosteroids and rare risks [26,27].…”

Section: Discussionsupporting

confidence: 91%

Patient preferences for maintenance therapy in Crohn’s disease: A discrete-choice experiment

et al. 2020

View full text Add to dashboard Cite

Objective To quantify patient preferences for maintenance therapy of Crohn's disease and understand the impact on treatment selection. Methods We conducted a discrete-choice experiment in patients with Crohn's disease (n = 155) to measure the importance of attributes relevant to choosing between different medical therapies for maintenance of Crohn's disease. The attributes included efficacy and withdrawals due to adverse events, as well as dosing and other rare risks of treatment. From the discrete-choice experiment we estimated the part-worth (importance) of each attribute level, and explored preference heterogeneity through latent class analysis. We then used the part-worths to apply weights across each outcome from a prior network meta-analysis to estimate patients' preferred treatment in pairwise comparisons and for the overall group of treatments. Results The discrete-choice experiment revealed that maintaining remission was the most important attribute. Patients would accept a rare risk of infection or cancer for a 14% absolute increased chance of remission. Latent class analysis demonstrated that 45% of the cohort was risk averse, either to adverse events or requiring a course of prednisone. When these preferences were used in modelling studies to compare pairs of treatments, there was a � 78% probability that all biologic treatments were preferred to azathioprine and methotrexate,

show abstract

Section: Discussionsupporting

confidence: 91%

Patient preferences for maintenance therapy in Crohn’s disease: A discrete-choice experiment

et al. 2020

View full text Add to dashboard Cite

show abstract

“…Therefore, a large impact may be achieved by engaging patients in decision making surrounding their choice of infused versus non-infused biologic agents. Patient preferences regarding perceived risks and benefits of treatment, as well as method of administration (oral, injected, intravenous) and location of therapy (home, medical office, hospital center) are crucial in developing successful treatment plans 7,8,10,11. In previous reports, some patients, when asked, prefer intravenous therapies over other parenterally administered options 2,5,6,8.…”

Section: Discussionmentioning

confidence: 99%

Patient preferences and satisfaction in a multispecialty infusion center

Ostrov¹,

Reynolds²,

Scalzi³

2014

PPA

View full text Add to dashboard Cite

PurposeDirect feedback from patients about their preferred modes of medication administration has been increasingly sought by providers to develop care programs that best match patient goals. Multispecialty infusion centers generally provide care to hematology–oncology (HO) and non-HO patients in one unit, with the same nursing staff. Our staff perceived that this was dissatisfying to our non-HO patients. We assessed patient satisfaction, as well as nursing and physician perceptions of patient preference/satisfaction with our infusion center, to determine whether a separate unit should be recommended when designing our new Cancer Institute Infusion Center.Patients and methodsA seven-question Likert scale satisfaction survey for patients, and a separate survey to assess nurses’ and physicians’ perception of patient satisfaction, were developed. The survey was administered to non-HO patients receiving infusions, doctors prescribing infusions, and nurses administering infusions. Results of the survey were compared between groups to assess differences in responses.ResultsResponses were received from 52 non-HO patients, 18 physicians, and 13 nurses. Patients had more satisfaction, on all survey items, with the multispecialty infusion center than had been realized by physicians and nurses. Analysis demonstrated that patients were satisfied with care in a multispecialty infusion unit and were in favor of continuing their care in this combined center. Total scores of patient surveys were significantly different (P<0.001) from those of physicians and nurses, who had assumed patients would prefer to have their care in a non-HO infusion setting.ConclusionUnderstanding patient preferences is an important step in deciding the structure of infusion centers. Based on these survey conclusions, a combined multispecialty infusion center has been continued at our institution, thus improving quality by including patients in decision-making affecting their care.

show abstract

“…Given the variety of issues facing IBD patients and their providers, a number of studies have used survey methods to obtain information on a range of issues [14]. However, we have been unable to find any research work on SDM among Japanese IBD patients.…”

Section: Introductionmentioning

confidence: 96%

“…There is no cure for either CD or UC, and these patients face numerous decisions regarding treatment of their disease [13]. Several therapeutic strategies, including the wide use of immunosuppressants, have been advocated in the treatment of CD and UC, each with its own risks and benefits [9, 14]. …”

Section: Introductionmentioning

confidence: 99%

Preferences Regarding Shared Decision-Making in Japanese Inflammatory Bowel Disease Patients

Morishige¹,

Nakajima²,

Yoshizawa³

et al. 2016

Adv Ther

View full text Add to dashboard Cite

IntroductionRecent studies have indicated that patients are showing increased interest in playing a larger role in making decisions regarding their medical treatment. Inflammatory bowel disease (IBD) is a chronic disease that manifests either as Crohn’s disease (CD) or ulcerative colitis (UC). IBD treatment is multifaceted and dependent on patient-specific factors. The selection of treatment options is mostly driven by physicians, and it is unclear to what degree patients are involved in shared decision-making (SDM). The objective of the current study is to assess preferences among Japanese patients with IBD in regard to SDM during their treatment for IBD.MethodsA nationwide web-based survey was performed in Japan during February 2016. The patients were asked for their basic clinical characteristics, socioeconomic status, medical history, treatment details, and preferences regarding SDM in IBD treatment. Differences were analyzed by chi-square, t tests, a multiple regression analysis, and ordered logistic regression analysis.ResultsIn response to the screening survey, a total of 1068 Japanese nationals met the inclusion criteria for this study of being patients diagnosed with IBD who are currently receiving treatment. Of these, 235 had CD and 800 UC; 33 were not specified. Overall, the majority of these patients felt that SDM was very important. Furthermore, interest in SDM was strongly associated with certain disease comorbidities, surgical history, and current treatment, although there were some differences in the results between CD and UC.ConclusionThe present study found that the majority of IBD patients in Japan wanted to have a role in their treatment plan. The results indicate that the patient’s preference in regard to SDM was driven by their perception of the severity or progression of their disease.FundingJanssen Pharmaceuticals.

show abstract

Assessing Patient Preferences for Treatment Options and Process of Care in Inflammatory Bowel Disease: A Critical Review of Quantitative Data

Cited by 39 publications

References 141 publications

Patient preferences for maintenance therapy in Crohn’s disease: A discrete-choice experiment

Patient preferences for maintenance therapy in Crohn’s disease: A discrete-choice experiment

Patient preferences and satisfaction in a multispecialty infusion center

Preferences Regarding Shared Decision-Making in Japanese Inflammatory Bowel Disease Patients

Contact Info

Product

Resources

About